Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by WAYNE GOODMAN and ERIC STORCH.
WAYNE GOODMAN
Connection Strength
30.435
ERIC STORCH
  1. Randomized trial comparing standard versus light intensity parent training for anxious youth. Behav Res Ther. 2024 02; 173:104451.
    View in: PubMed
    Score: 0.903
  2. Obsessive Compulsive and Related Disorders. Psychiatr Clin North Am. 2023 03; 46(1):xiii-xv.
    View in: PubMed
    Score: 0.843
  3. Response to: Optimizing DBS Stimulation Parameters in Obsessive-Compulsive Disorder. Neuromodulation. 2021 Feb; 24(2):400.
    View in: PubMed
    Score: 0.740
  4. Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder. Psychiatry Res. 2021 01; 295:113597.
    View in: PubMed
    Score: 0.731
  5. Moderators and predictors of response to deep transcranial magnetic stimulation for obsessive-compulsive disorder. J Psychiatr Res. 2021 04; 136:508-514.
    View in: PubMed
    Score: 0.729
  6. Impact of COVID-19 on exposure and response prevention for obsessive-compulsive disorder: Present and post-pandemic considerations. Psychiatry Res. 2020 10; 292:113310.
    View in: PubMed
    Score: 0.713
  7. Little Doubt That CBT Works for Pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):785-787.
    View in: PubMed
    Score: 0.710
  8. Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified. Front Psychiatry. 2020; 11:363.
    View in: PubMed
    Score: 0.702
  9. Psychiatric Diagnoses and Medications for Hurricane Harvey Sheltered Evacuees. Community Ment Health J. 2019 10; 55(7):1099-1102.
    View in: PubMed
    Score: 0.650
  10. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition. J Am Acad Child Adolesc Psychiatry. 2019 01; 58(1):92-98.
    View in: PubMed
    Score: 0.632
  11. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Psychol Assess. 2010 Jun; 22(2):223-32.
    View in: PubMed
    Score: 0.353
  12. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. J Anxiety Disord. 2010 Aug; 24(6):650-6.
    View in: PubMed
    Score: 0.351
  13. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 2008 Aug 15; 160(2):212-20.
    View in: PubMed
    Score: 0.308
  14. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008 May; 47(5):583-592.
    View in: PubMed
    Score: 0.306
  15. Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety. 2008; 25(4):336-47.
    View in: PubMed
    Score: 0.299
  16. Cognitive-behavioral therapy for obsessive-compulsive disorder: a non-randomized comparison of intensive and weekly approaches. J Anxiety Disord. 2008 Oct; 22(7):1146-58.
    View in: PubMed
    Score: 0.298
  17. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand. 2008 Jan; 117(1):67-75.
    View in: PubMed
    Score: 0.296
  18. Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2008 Jun; 22(5):877-85.
    View in: PubMed
    Score: 0.293
  19. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9.
    View in: PubMed
    Score: 0.292
  20. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7.
    View in: PubMed
    Score: 0.289
  21. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther. 2007 Nov; 45(11):2593-603.
    View in: PubMed
    Score: 0.288
  22. Clinical features of children and adolescents with obsessive-compulsive disorder and hoarding symptoms. Compr Psychiatry. 2007 Jul-Aug; 48(4):313-8.
    View in: PubMed
    Score: 0.286
  23. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007 Apr; 46(4):469-478.
    View in: PubMed
    Score: 0.284
  24. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81.
    View in: PubMed
    Score: 0.279
  25. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007 Mar; 191(1):87-96.
    View in: PubMed
    Score: 0.278
  26. Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatry Res. 2007 Jan 15; 149(1-3):231-7.
    View in: PubMed
    Score: 0.277
  27. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1171-8.
    View in: PubMed
    Score: 0.274
  28. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord. 2006; 20(8):1055-70.
    View in: PubMed
    Score: 0.263
  29. Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder. Depress Anxiety. 2006; 23(7):429-33.
    View in: PubMed
    Score: 0.260
  30. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005 Dec; 17(4):486-91.
    View in: PubMed
    Score: 0.259
  31. Factor analytic study of the Children's Yale-Brown Obsessive-Compulsive Scale. J Clin Child Adolesc Psychol. 2005 Jun; 34(2):312-9.
    View in: PubMed
    Score: 0.250
  32. Effects of Stepped Cognitive Behavioral Therapy on Child Depressive and Externalizing Symptoms in Autistic Children With Anxiety. Am J Intellect Dev Disabil. 2025 May 01; 130(3):228-243.
    View in: PubMed
    Score: 0.248
  33. Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale - Second Edition. Psychiatry Res. 2025 Jun; 348:116456.
    View in: PubMed
    Score: 0.247
  34. High intensity approaches to exposure and response prevention for obsessive-compulsive disorder. Behav Brain Res. 2025 Mar 12; 481:115427.
    View in: PubMed
    Score: 0.243
  35. Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited. Depress Anxiety. 2005; 22(1):28-35.
    View in: PubMed
    Score: 0.243
  36. Problematic Substance Use in Depressed Youth: Associations with Suicidal Ideation and Suicide Attempt History. J Dual Diagn. 2025 Jan-Mar; 21(1):35-48.
    View in: PubMed
    Score: 0.241
  37. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004 Nov 30; 129(1):91-8.
    View in: PubMed
    Score: 0.241
  38. Psychometric Properties of the Yale-Brown Obsessive Compulsive Scale-II Self-Report. J Psychiatr Pract. 2024 Nov 01; 30(6):421-427.
    View in: PubMed
    Score: 0.240
  39. Parent perceptions of various treatment approaches for PANS and PANDAS. J Affect Disord. 2025 Jan 15; 369:1215-1222.
    View in: PubMed
    Score: 0.240
  40. Misconceptions Among Mental Health Treatment Providers About OCD and PTSD. Behav Ther. 2025 05; 56(3):470-486.
    View in: PubMed
    Score: 0.238
  41. Obsessive-Compulsive Disorder in Children and Adolescents. Annu Rev Clin Psychol. 2024 Jul; 20(1):355-380.
    View in: PubMed
    Score: 0.234
  42. Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Paediatr Drugs. 2024 Jul; 26(4):397-409.
    View in: PubMed
    Score: 0.234
  43. Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis. J Child Psychol Psychiatry. 2024 05; 65(5):594-609.
    View in: PubMed
    Score: 0.227
  44. Perceived worsening of obsessive-compulsive disorder symptoms after childbirth in women and men: An understudied phenomenon. Bull Menninger Clin. 2024; 88(1):48-60.
    View in: PubMed
    Score: 0.226
  45. Further psychometric properties of the Tourette's Disorder Scale-Parent Rated version (TODS-PR). Child Psychiatry Hum Dev. 2004; 35(2):107-20.
    View in: PubMed
    Score: 0.226
  46. Corrigendum to "Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia" [J. Affect. Disord. volume 324 (2023) 395-402]. J Affect Disord. 2024 Mar 01; 348:410.
    View in: PubMed
    Score: 0.225
  47. Alterations in attentional processing in youth with misophonia: A phenotypical cross-comparison with anxiety patients. J Affect Disord. 2024 02 15; 347:429-436.
    View in: PubMed
    Score: 0.225
  48. Depressive symptoms during deep transcranial magnetic stimulation or sham treatment for obsessive-compulsive disorder. J Affect Disord. 2024 01 01; 344:466-472.
    View in: PubMed
    Score: 0.223
  49. Predictors and Moderators of Treatment Outcomes for Anxious Children Randomized to Computer-Assisted Cognitive Behavioral Therapy or Standard Community Care. J Child Adolesc Psychopharmacol. 2023 10; 33(8):316-324.
    View in: PubMed
    Score: 0.223
  50. Family Accommodation in Children and Adolescents With Misophonia. Behav Ther. 2024 05; 55(3):595-604.
    View in: PubMed
    Score: 0.222
  51. Parent-Led Cognitive Behavioral Teletherapy for Anxiety in Autistic Youth: A Randomized Trial Comparing Two Levels of Therapist Support. Behav Ther. 2024 05; 55(3):499-512.
    View in: PubMed
    Score: 0.221
  52. Psychometric properties of the revised children's anxiety and depression scale (RCADS) for autistic youth without co-occurring intellectual disability. J Mood Anxiety Disord. 2023 Aug; 2.
    View in: PubMed
    Score: 0.220
  53. Geospatial Distribution of Obsessive-Compulsive Disorder Specialists: Understanding Access as a Function of Distance, Insurance Status, and Neighborhood Socioeconomic Status. J Obsessive Compuls Relat Disord. 2023 Jul; 38.
    View in: PubMed
    Score: 0.220
  54. Obsessive-compulsive disorder in youth and young adults with depression: Clinical characteristics of comorbid presentations. J Obsessive Compuls Relat Disord. 2023 Jul; 38.
    View in: PubMed
    Score: 0.218
  55. Measuring misophonia in youth: A psychometric evaluation of child and parent measures. J Affect Disord. 2023 10 01; 338:180-186.
    View in: PubMed
    Score: 0.217
  56. A systematic review of treatments for misophonia. Pers Med Psychiatry. 2023 Jul-Aug; 39-40.
    View in: PubMed
    Score: 0.216
  57. Attenuating side effects of deep brain stimulation in the bed nucleus of the stria terminalis for obsessive compulsive disorder using current-steering strategies. Brain Stimul. 2023 Mar-Apr; 16(2):650-652.
    View in: PubMed
    Score: 0.215
  58. Promoting OCD WEllness and resilience (POWER) study: Rationale, design, and methods. Psychiatry Res Commun. 2023 Jun; 3(2).
    View in: PubMed
    Score: 0.214
  59. Examining the Relationship Between Anxiety Severity and Autism-Related Challenges During Cognitive Behavioral Therapy for Children with Autism. J Autism Dev Disord. 2024 May; 54(5):1849-1856.
    View in: PubMed
    Score: 0.214
  60. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study Protocol. medRxiv. 2023 Feb 26.
    View in: PubMed
    Score: 0.214
  61. Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review. Pharmacoeconomics. 2023 05; 41(5):499-527.
    View in: PubMed
    Score: 0.214
  62. Brain Imaging in Psychiatry: Time to Move From Regions of Interest and Interpretive Analyses to Connectomes and Predictive Modeling? Am J Psychiatry. 2023 01 01; 180(1):17-19.
    View in: PubMed
    Score: 0.211
  63. COVID-19-related intrusive thoughts and associated ritualistic behaviors. Bull Menninger Clin. 2023; 87(3):225-249.
    View in: PubMed
    Score: 0.211
  64. Anger Outbursts in Youth with ASD and Anxiety: Phenomenology and Relationship with Family Accommodation. Child Psychiatry Hum Dev. 2024 Oct; 55(5):1259-1268.
    View in: PubMed
    Score: 0.211
  65. Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia. J Affect Disord. 2023 03 01; 324:395-402.
    View in: PubMed
    Score: 0.211
  66. Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder. Psychiatr Clin North Am. 2023 03; 46(1):167-180.
    View in: PubMed
    Score: 0.211
  67. The Relationship Between Adverse Childhood Experiences, Symptom Severity, Negative Thinking, Comorbidity, and Treatment Response in Youth with Obsessive-Compulsive Disorder. Child Psychiatry Hum Dev. 2024 Oct; 55(5):1201-1210.
    View in: PubMed
    Score: 0.211
  68. Stepped-Care Cognitive Behavioral Therapy in Children on the Autism Spectrum with Co-occurring Anxiety. J Autism Dev Disord. 2024 Jan; 54(1):93-108.
    View in: PubMed
    Score: 0.208
  69. Perceptions of various treatment approaches for adults and children with misophonia. J Affect Disord. 2022 11 01; 316:76-82.
    View in: PubMed
    Score: 0.206
  70. Provider perceptions of telehealth and in-person exposure and response prevention for obsessive-compulsive disorder. Psychiatry Res. 2022 07; 313:114610.
    View in: PubMed
    Score: 0.202
  71. Primary Outcomes for Adults Receiving the Unified Protocol after Hurricane Harvey in an Integrated Healthcare Setting. Community Ment Health J. 2022 11; 58(8):1522-1534.
    View in: PubMed
    Score: 0.201
  72. Obsessive compulsive disorder during the COVID-19 pandemic: A brief review of course, psychological assessment and treatment considerations. J Obsessive Compuls Relat Disord. 2022 Apr; 33:100722.
    View in: PubMed
    Score: 0.199
  73. Brief, parent-led, transdiagnostic cognitive-behavioral teletherapy for youth with emotional problems related to the COVID-19 pandemic. J Affect Disord. 2022 Mar 15; 301:130-137.
    View in: PubMed
    Score: 0.198
  74. Anxiety in Angelman Syndrome. Am J Intellect Dev Disabil. 2022 01 01; 127(1):1-10.
    View in: PubMed
    Score: 0.197
  75. Cost-effectiveness analysis of deep transcranial magnetic stimulation relative to evidence-based strategies for treatment-refractory obsessive-compulsive disorder. J Psychiatr Res. 2022 02; 146:50-54.
    View in: PubMed
    Score: 0.197
  76. A Qualitative Inquiry of Parents' Observations of Their Children's Mental Health Needs During the COVID-19 Pandemic. Child Health Care. 2022; 51(2):213-234.
    View in: PubMed
    Score: 0.196
  77. Obsessive-Compulsive Disorder Misdiagnosis among Mental Healthcare Providers in Latin America. J Obsessive Compuls Relat Disord. 2022 Jan; 32.
    View in: PubMed
    Score: 0.195
  78. Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review. Curr Psychiatry Rep. 2021 10 06; 23(11):71.
    View in: PubMed
    Score: 0.194
  79. Addressing the mental health needs of learners and nonlearners in an academic medical center during COVID-19. Bull Menninger Clin. 2021; 85(3):283-297.
    View in: PubMed
    Score: 0.188
  80. Family accommodation in Chinese individuals with obsessive-compulsive disorder. Psych J. 2021 Apr; 10(2):295-304.
    View in: PubMed
    Score: 0.185
  81. Age moderated-anxiety mediation for multimodal treatment outcome among children with obsessive-compulsive disorder: An evaluation with correspondence analysis. J Affect Disord. 2021 03 01; 282:766-775.
    View in: PubMed
    Score: 0.184
  82. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry. 2021 01 01; 178(1):17-29.
    View in: PubMed
    Score: 0.184
  83. Neural correlates of cognitive behavioral therapy response in youth with negative valence disorders: A systematic review of the literature. J Affect Disord. 2021 03 01; 282:1288-1307.
    View in: PubMed
    Score: 0.184
  84. Deep transcranial magnetic stimulation for obsessive compulsive disorder. Expert Rev Neurother. 2020 10; 20(10):1029-1036.
    View in: PubMed
    Score: 0.179
  85. Deep Brain Stimulation for Intractable Obsessive-Compulsive Disorder: Progress and Opportunities. Am J Psychiatry. 2020 03 01; 177(3):200-203.
    View in: PubMed
    Score: 0.174
  86. Parent-led Behavioral Intervention for a Treatment-refusing Adult With Obsessive-Compulsive Disorder With Poor Insight and Extreme Family Accommodation. J Psychiatr Pract. 2020 03; 26(2):149-152.
    View in: PubMed
    Score: 0.174
  87. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020 05; 37(5):418-428.
    View in: PubMed
    Score: 0.173
  88. Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder. Expert Rev Neurother. 2020 01; 20(1):95-107.
    View in: PubMed
    Score: 0.170
  89. Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder. J Anxiety Disord. 2020 01; 69:102151.
    View in: PubMed
    Score: 0.170
  90. Chinese Therapists' Beliefs About Exposure Therapy for Anxiety and Obsessive-Compulsive Disorders. J Psychiatr Pract. 2019 05; 25(3):179-185.
    View in: PubMed
    Score: 0.164
  91. Incidence and clinical correlates of anger attacks in Chinese patients with obsessive-compulsive disorder. J Zhejiang Univ Sci B. 2019 Apr.; 20(4):363-370.
    View in: PubMed
    Score: 0.163
  92. Cognitive Behavioral Therapy for Childhood Anxiety Disorders: a Review of Recent Advances. Curr Psychiatry Rep. 2018 07 28; 20(8):65.
    View in: PubMed
    Score: 0.155
  93. Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration. J Clin Psychol. 2018 05; 74(5):750-754.
    View in: PubMed
    Score: 0.151
  94. Meeting the Mental Health Needs of Hurricane Harvey Evacuees. Am J Psychiatry. 2018 Jan 01; 175(1):13-14.
    View in: PubMed
    Score: 0.149
  95. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9.
    View in: PubMed
    Score: 0.111
  96. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32.
    View in: PubMed
    Score: 0.109
  97. Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Res. 2013 Feb 28; 205(3):253-61.
    View in: PubMed
    Score: 0.104
  98. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr. 2012 Feb; 160(2):314-9.
    View in: PubMed
    Score: 0.096
  99. The role of avoidance in the phenomenology of obsessive-compulsive disorder. Compr Psychiatry. 2012 Feb; 53(2):187-94.
    View in: PubMed
    Score: 0.094
  100. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6.
    View in: PubMed
    Score: 0.091
  101. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res. 2011 Feb 28; 185(3):394-401.
    View in: PubMed
    Score: 0.090
  102. Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile. Child Youth Care Forum. 2010 Feb 04; 39(2):113-124.
    View in: PubMed
    Score: 0.086
  103. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009 Sep; 40(3):467-83.
    View in: PubMed
    Score: 0.081
  104. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009 Nov; 44(11):935-42.
    View in: PubMed
    Score: 0.081
  105. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist. J Clin Psychol. 2008 Dec; 64(12):1338-51.
    View in: PubMed
    Score: 0.080
  106. Further psychometric analysis of the Florida Obsessive-Compulsive Inventory. J Anxiety Disord. 2009 Jan; 23(1):124-9.
    View in: PubMed
    Score: 0.077
  107. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping. 2008 Apr; 21(2):199-212.
    View in: PubMed
    Score: 0.076
  108. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008 Apr; 20(2):203-8.
    View in: PubMed
    Score: 0.076
  109. Obsessive-compulsive disorder in youth with and without a chronic tic disorder. Depress Anxiety. 2008; 25(9):761-7.
    View in: PubMed
    Score: 0.075
  110. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry. 2008 Jan-Feb; 49(1):35-42.
    View in: PubMed
    Score: 0.073
  111. A measure of functional impairment in youth with Tourette's syndrome. J Pediatr Psychol. 2007 Sep; 32(8):950-9.
    View in: PubMed
    Score: 0.072
  112. Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):207-16.
    View in: PubMed
    Score: 0.071
  113. Quality of life in youth with Tourette's syndrome and chronic tic disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):217-27.
    View in: PubMed
    Score: 0.071
  114. Further psychometric examination of the Tourette's Disorder Scales. Child Psychiatry Hum Dev. 2007 Aug; 38(2):89-98.
    View in: PubMed
    Score: 0.069
  115. Peer victimization in children with obsessive-compulsive disorder: relations with symptoms of psychopathology. J Clin Child Adolesc Psychol. 2006 Sep; 35(3):446-55.
    View in: PubMed
    Score: 0.068
  116. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14.
    View in: PubMed
    Score: 0.068
  117. Cognitive-behavioral treatment for obsessive-compulsive disorder in an elderly male with concurrent medical constraints. Am J Geriatr Psychiatry. 2006 Apr; 14(4):380-1.
    View in: PubMed
    Score: 0.066
  118. Hope and coping in family members of patients with obsessive-compulsive disorder. J Anxiety Disord. 2006; 20(5):614-29.
    View in: PubMed
    Score: 0.063
  119. Reliability and validity of the Child Behavior Checklist Obsessive-Compulsive Scale. J Anxiety Disord. 2006; 20(4):473-85.
    View in: PubMed
    Score: 0.063
  120. Author Correction: Disruption of neural periodicity predicts clinical response after deep brain stimulation for obsessive-compulsive disorder. Nat Med. 2025 May; 31(5):1716.
    View in: PubMed
    Score: 0.062
  121. High beta power in the ventrolateral prefrontal cortex indexes human approach behavior: a case study. J Neurosci. 2025 Jan 31.
    View in: PubMed
    Score: 0.061
  122. Cost-effectiveness analysis of deep brain stimulation versus treatment as usual for treatment-resistant obsessive-compulsive disorder. J Neurosurg. 2025 May 01; 142(5):1225-1234.
    View in: PubMed
    Score: 0.061
  123. Cognitive-behavioral therapy for obsessive-compulsive disorder: review of treatment techniques. J Psychosoc Nurs Ment Health Serv. 2004 Dec; 42(12):44-51.
    View in: PubMed
    Score: 0.060
  124. Effective deep brain stimulation for obsessive-compulsive disorder after failed anterior capsulotomy: illustrative cases. J Neurosurg Case Lessons. 2024 Oct 28; 8(18).
    View in: PubMed
    Score: 0.060
  125. Disruption of neural periodicity predicts clinical response after deep brain stimulation for obsessive-compulsive disorder. Nat Med. 2024 Oct; 30(10):3004-3014.
    View in: PubMed
    Score: 0.059
  126. Multimodal Prediction of Obsessive-Compulsive Disorder and Comorbid Depression Severity and Energy Delivered by Deep Brain Electrodes. IEEE Trans Affect Comput. 2024 Oct-Dec; 15(4):2025-2041.
    View in: PubMed
    Score: 0.058
  127. Co-occurring PTSD in intensive OCD treatment: Impact on treatment trajectory vs. response. J Affect Disord. 2024 05 15; 353:109-116.
    View in: PubMed
    Score: 0.057
  128. The clinical presentation of major depressive disorder in youth with co-occurring obsessive-compulsive disorder. J Affect Disord. 2024 03 15; 349:349-357.
    View in: PubMed
    Score: 0.057
  129. Dual-Target Deep Brain Stimulation for Obsessive-Compulsive Disorder and Tourette Syndrome. Biol Psychiatry. 2023 06 01; 93(11):e53-e55.
    View in: PubMed
    Score: 0.053
  130. Tractography-Based Modeling Explains Treatment Outcomes in Patients Undergoing Deep Brain Stimulation for Obsessive-Compulsive Disorder. Biol Psychiatry. 2024 Jul 15; 96(2):95-100.
    View in: PubMed
    Score: 0.053
  131. Neurosurgical Approaches for Treatment-Resistant Obsessive-Compulsive Disorder. Psychiatr Clin North Am. 2023 03; 46(1):121-132.
    View in: PubMed
    Score: 0.053
  132. Intraoperative valence testing to adjudicate between ventral capsule/ventral striatum and bed nucleus of the stria terminalis target selection in deep brain stimulation for obsessive-compulsive disorder. J Neurosurg. 2023 08 01; 139(2):442-450.
    View in: PubMed
    Score: 0.053
  133. Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022 Sep 20.
    View in: PubMed
    Score: 0.052
  134. Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder. J Neurosurg. 2023 02 01; 138(2):347-357.
    View in: PubMed
    Score: 0.051
  135. Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition. J Psychiatr Pract. 2022 07 01; 28(4):294-309.
    View in: PubMed
    Score: 0.051
  136. Family Accommodation of Symptoms in Adults With Obsessive-Compulsive Disorder: Factor Structure and Usefulness of the Family Accommodation Scale for OCD-Patient Version. J Psychiatr Pract. 2022 01 06; 28(1):36-47.
    View in: PubMed
    Score: 0.049
  137. Long-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorder. Nat Med. 2021 12; 27(12):2154-2164.
    View in: PubMed
    Score: 0.049
  138. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. J Am Acad Child Adolesc Psychiatry. 2022 04; 61(4):495-507.
    View in: PubMed
    Score: 0.048
  139. Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act. Front Psychiatry. 2021; 12:706181.
    View in: PubMed
    Score: 0.048
  140. Defining functional brain networks underlying obsessive-compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature. J Neurol Neurosurg Psychiatry. 2021 07; 92(7):776-786.
    View in: PubMed
    Score: 0.047
  141. Perceptions of Deep Brain Stimulation for Adolescents with Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2021 03; 31(2):109-117.
    View in: PubMed
    Score: 0.046
  142. The Relationship of Family Accommodation with Pediatric Anxiety Severity: Meta-analytic Findings and Child, Family and Methodological Moderators. Child Psychiatry Hum Dev. 2021 02; 52(1):1-14.
    View in: PubMed
    Score: 0.046
  143. Strategies to mitigate impacts of the COVID-19 pandemic on patients treated with deep brain stimulation. Brain Stimul. 2020 Nov - Dec; 13(6):1642-1643.
    View in: PubMed
    Score: 0.045
  144. The Impact of Comorbidity on Cognitive-Behavioral Therapy Response in Youth with Anxiety and Autism Spectrum Disorder. Child Psychiatry Hum Dev. 2020 08; 51(4):625-635.
    View in: PubMed
    Score: 0.045
  145. Neurostimulation for treatment-resistant posttraumatic stress disorder: an update on neurocircuitry and therapeutic targets. J Neurosurg. 2021 06 01; 134(6):1715-1723.
    View in: PubMed
    Score: 0.045
  146. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition. Braz J Psychiatry. 2019 Nov-Dec; 41(6):494-498.
    View in: PubMed
    Score: 0.042
  147. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.042
  148. The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in Youth. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):880-889.
    View in: PubMed
    Score: 0.042
  149. Parents' Perceptions of Internalizing and Externalizing Features in Childhood OCD. Child Psychiatry Hum Dev. 2019 08; 50(4):692-701.
    View in: PubMed
    Score: 0.042
  150. Neuroethics at 15: Keep the Kant but Add More Bacon. AJOB Neurosci. 2019 Jul-Sep; 10(3):97-100.
    View in: PubMed
    Score: 0.041
  151. Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD). Cogn Behav Ther. 2020 07; 49(4):294-306.
    View in: PubMed
    Score: 0.041
  152. Clinicians' perspectives of interfering behaviors in the treatment of anxiety and obsessive-compulsive disorders in adults and children. Cogn Behav Ther. 2020 01; 49(1):81-96.
    View in: PubMed
    Score: 0.041
  153. The Case for Adaptive Neuromodulation to Treat Severe Intractable Mental Disorders. Front Neurosci. 2019; 13:152.
    View in: PubMed
    Score: 0.040
  154. Politically-focused intrusive thoughts and associated ritualistic behaviors in a community sample. J Anxiety Disord. 2018 05; 56:35-42.
    View in: PubMed
    Score: 0.038
  155. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
    View in: PubMed
    Score: 0.036
  156. The link between ADHD-like inattention and obsessions and compulsions during treatment of youth with OCD. J Obsessive Compuls Relat Disord. 2017 Jan; 12:1-8.
    View in: PubMed
    Score: 0.035
  157. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7.
    View in: PubMed
    Score: 0.032
  158. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther. 2010; 39(1):24-7.
    View in: PubMed
    Score: 0.021
  159. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5.
    View in: PubMed
    Score: 0.020
  160. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist. J Anxiety Disord. 2008 Dec; 22(8):1369-76.
    View in: PubMed
    Score: 0.019
  161. Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry. 2007 Feb 01; 61(3):279-84.
    View in: PubMed
    Score: 0.017
  162. A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments. Neuropsychiatr Dis Treat. 2006 Mar; 2(1):21-31.
    View in: PubMed
    Score: 0.016
  163. Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology. Child Psychiatry Hum Dev. 2005; 36(2):195-214.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.